Answer to the letter to the editors by Matthes and colleagues regarding our systematic reviews on mistletoe

  • Jutta HuebnerEmail author
  • M. Freuding
  • C. Keinki
  • O. Micke
  • J. Buentzel
Letter to the Editors


Compliance with ethical standards

Conflict of interest

The authors declare no conflict.


  1. Horneber MA, Bueschel G, Huber R, Linde K, Rostock M (2008) Mistletoe therapy in oncology. Cochrane Database Syst Rev. PubMedGoogle Scholar
  2. Longhi A, Reif M, Mariani E, Ferrari S (2014) A randomized study on postrelapse disease-free survival with adjuvant mistletoe versus oral etoposide in osteosarcoma patients. Evid Based Complement Alternat Med 2014:210198. CrossRefPubMedGoogle Scholar
  3. Ostermann T, Raak C, Bussing A (2009) Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review. BMC Cancer 9:451CrossRefPubMedGoogle Scholar
  4. Tröger W, Galun D, Reif M, Schumann A, Stankovi N, Milićević M (2013) Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer 49:3788–3797. CrossRefPubMedGoogle Scholar
  5. Tröger W, Galun D, Reif M, Schumann A, Stankovi N, Milićević M (2014) Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Deutsches Arzteblatt International 111:493–502. PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Hämatologie und Internistische Onkologie, Klinik für Innere Medizin IIUniversitätsklinikum JenaJenaGermany
  2. 2.Klinik für Strahlentherapie und RadioonkologieFranziskus HospitalBielefeldGermany
  3. 3.Klinik für Hals-Nasen-Ohren-HeilkundeSüdharzklinikum NordhausenNordhausenGermany

Personalised recommendations